Peak Pharmaceuticals (PKPH) News Today → America’s worst nightmare? (From Porter & Company) (Ad) Free PKPH Stock Alerts $5.20 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 2, 2024 | bbc.co.ukDaytime and early peak commissioningMarch 5, 2024 | marketwatch.comAkari Therapeutics Signs Merger-of-Equals with Peak BioMarch 5, 2024 | markets.businessinsider.comAkari Therapeutics, Peak Bio Announces Agreement To Merge As Equals - Quick FactsJanuary 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Longboard Pharmaceuticals Amid Strong Bexicaserin Phase 2 Results and Blockbuster Revenue PotentialJune 14, 2023 | dailymail.co.ukPeak Practice is axedMay 31, 2023 | benzinga.comPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 31, 2023 | finance.yahoo.comPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 2, 2023 | usnews.comPeak to Peak Charter SchoolMarch 28, 2023 | finance.yahoo.comPeak Pharmaceuticals Merges with Retrieve Medical, Inc.February 23, 2023 | seekingalpha.comPKPHD Peak Pharmaceuticals, Inc.February 14, 2023 | finance.yahoo.comPeak Pharmaceuticals Announces One-for-Two-Hundred Reverse Stock SplitFebruary 14, 2023 | finanznachrichten.dePeak Pharmaceuticals, Inc.: Peak Pharmaceuticals Announces One-for-Two-Hundred Reverse Stock SplitFebruary 1, 2023 | seekingalpha.comMirum Pharmaceuticals: In The Spotlight Following Buyout Of Albireo PharmaJanuary 30, 2023 | cnbc.comBMO says this stock taking gene therapy to the 'next level' can more than doubleJanuary 10, 2023 | msn.comShould You Buy Biogen Stock After Its Latest Alzheimer's Disease Drug Approval?November 29, 2022 | cnbc.comHorizon Therapeutics fields buyout interest from Amgen, J&J and SanofiOctober 15, 2022 | seekingalpha.comPKPH Peak Pharmaceuticals, Inc.October 3, 2022 | reuters.comPeak Pharmaceuticals IncJune 14, 2022 | benzinga.comCannabis And PsychedelicsSeptember 9, 2021 | benzinga.comGood News For NY Cannabis Market Though Sales Won't Start Until 2023 Amid Regulatory UncertaintySeptember 9, 2021 | benzinga.comAUDACIOUS Teams Up With Professional Bull Riders On New CBD ProductsAugust 8, 2021 | benzinga.comGoing To Space Isn't The Only Way Jeff Bezos Wants To Get HighAugust 6, 2021 | barrons.comPeak Pharmaceuticals Inc.July 23, 2021 | benzinga.comNew York State Senator Aims To Speed Up Legal Cannabis Program Launch With New Cultivation Bill Get Peak Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PKPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Does this chart look familiar? (Ad)Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above… Get all the information here. PKPH Media Mentions By Week PKPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PKPH News Sentiment▼0.000.58▲Average Medical News Sentiment PKPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PKPH Articles This Week▼00▲PKPH Articles Average Week Get Peak Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PKPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BPTH News Today GLMD News Today CMND News Today PXMD News Today DRMA News Today SLRX News Today QLGN News Today CNSP News Today ALLR News Today CWBR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PKPH) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsHow Biden has already won 2024Porter & CompanyUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
